These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 7039445

  • 1. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
    Glueck CJ.
    Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
    [Abstract] [Full Text] [Related]

  • 2. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [Abstract] [Full Text] [Related]

  • 3. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    Kuo PT, Wilson AC, Kostis JB, Moreyra AE.
    Am J Cardiol; 1986 Jun 27; 57(16):43H-48H. PubMed ID: 3524177
    [Abstract] [Full Text] [Related]

  • 4. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
    Dujovne CA, Krehbiel P, Chernoff SB.
    Am J Cardiol; 1986 Jun 27; 57(16):36H-42H. PubMed ID: 3524176
    [Abstract] [Full Text] [Related]

  • 5. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G, Witztum J, Basich P.
    Artery; 1982 Jun 27; 10(2):99-104. PubMed ID: 7092583
    [Abstract] [Full Text] [Related]

  • 6. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA, Krehbiel P, Decoursey S, Jackson B, Chernoff SB, Pitterman A, Garty M.
    Ann Intern Med; 1984 Apr 27; 100(4):477-82. PubMed ID: 6367578
    [Abstract] [Full Text] [Related]

  • 7. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
    Valeri A, Gelfand J, Blum C, Appel GB.
    Am J Kidney Dis; 1986 Dec 27; 8(6):388-96. PubMed ID: 3544820
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
    Tikkanen MJ, Helve E, Nikkilä EA.
    Eur Heart J; 1987 Aug 27; 8 Suppl E():97-101. PubMed ID: 3315684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP, Helve E, Karjalainen K, Tarkkanen A, Tikkanen MJ.
    Atherosclerosis; 1990 May 27; 82(1-2):85-95. PubMed ID: 2360923
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
    Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML, Rowe JS, Havel RJ.
    N Engl J Med; 1981 Jan 29; 304(5):251-8. PubMed ID: 7003391
    [Abstract] [Full Text] [Related]

  • 19. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R, Gasparotto A, Valerio G, Baiocchi MR, Padrini R, Lamon S, Vitale E, Baggio G, Crepaldi G.
    Atherosclerosis; 1986 Jan 29; 59(1):47-56. PubMed ID: 3081013
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.